Investors Supporting Innovation through Patient Engagement: Discussing Strategies for MedTech

Building on the momentum of our Investors and Patient Engagement series, this second roundtable will focus on strategies for integrating patient engagement into MedTech.

As the healthcare sector continues to evolve, there is increasing attention on making care more individual-centric and aligned with value-based models. Investors are recognizing the growing importance of real-world data (RWD) and patient preferences, particularly in the context of regulatory shifts and the rise of B2C medical devices. While not yet universally adopted, these approaches present opportunities for innovation and sustainable impact in MedTech.

This session will explore how patient engagement can inform investment decisions and support portfolio companies in developing products that better align with market demands and individual needs.

Key discussion points include:

• The Value of Patient Engagement in MedTech: Beyond being a de-risking strategy for investors, how do startups perceive and leverage patient engagement at different stages of development?

• Overcoming the Access Barrier: How can investors help portfolio companies engage end-users effectively, and what lessons can be learned from B2C models in validating MedTech solutions before transitioning to B2B?

• Timing & Strategy of Patient Involvement: When should MedTech companies engage patients to maximize impact, and how can they navigate regulatory challenges while leveraging patient insights for market differentiation?

Through real-world examples and interactive discussion, this roundtable will provide actionable insights for investors and MedTech companies aiming to integrate patient engagement not just as a compliance measure but as a core driver of market success.